Recurrence detection by Fluorodeoxyglucose (FDG) and Positron Emission Tomography (PET)/Computed Tomography (CT) in risk categories of breast cancer

被引：0
|
作者：
Evangelista, L. [1 ]
Cervino, A. R. [1 ]
Vinante, L. [2 ]
Zago, G. [3 ]
Ghiotto, C. [3 ]
Bozza, F. [4 ]
Burei, M. [1 ]
Gregianin, M. [1 ]
Saladini, G. [1 ]
机构：
[1] Ist Oncol Veneto, Nucl Med Unit, Padua, Italy
[2] Ist Oncol Veneto, Radiotherapy Unit, Padua, Italy
[3] Ist Oncol Veneto, Oncol Unit 2, Padua, Italy
[4] Ist Oncol Veneto, Surg Oncol Unit, Padua, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP639
引用
收藏
页码：S283 / S283
页数：1
相关论文
共 50 条
  • [1] Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer
    Goh, Vicky
    Cook, Gary
    [J]. BJU INTERNATIONAL, 2013, 112 (06) : 709 - 709
  • [2] Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer
    Goodfellow, Henry
    Viney, Zaid
    Hughes, Paul
    Rankin, Sheila
    Rottenberg, Giles
    Hughes, Simon
    Evison, Felicity
    Dasgupta, Prokar
    O'Brien, Timothy
    Khan, Muhammad Shamim
    [J]. BJU INTERNATIONAL, 2014, 114 (03) : 389 - 395
  • [3] An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
    Auguste, P.
    Barton, P.
    Hyde, C.
    Roberts, T. E.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (18) : 1 - +
  • [4] A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
    Pennant, M.
    Takwoingi, Y.
    Pennant, L.
    Davenport, C.
    Fry-Smith, A.
    Eisinga, A.
    Andronis, L.
    Arvanitis, T.
    Deeks, J.
    Hyde, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (50) : 1 - +
  • [5] The use of [18F]-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) for predicting recurrence in cervical cancer patients
    Brunette, L.
    Mehta, A.
    Lieber, D.
    Bonyadlou, S.
    Lin, Y.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 389 - 389
  • [6] Fluorodeoxyglucose (FDG)-avidity at positron emission computed tomography/computed tomography (PET/CT) during adjuvant hormonal therapy (HT) in breast cancer (BC) patients
    Evangelista, L.
    Redana, S.
    Racca, M.
    Geuna, E.
    Gucalp, A.
    Vinante, L.
    De Carolis, V.
    Ghiotto, C.
    Zago, G.
    Fornier, M. N.
    Varetto, T.
    Saladini, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S217 - S217
  • [7] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
    Alberini, Jean-Louis
    Lerebours, Florence
    Wartski, Myriam
    Fourme, Emmanuelle
    Le Stanc, Elise
    Gontier, E.
    Madar, O.
    Cherel, P.
    Pecking, A. P.
    [J]. CANCER, 2009, 115 (21) : 5038 - 5047
  • [8] Role of positron-emission tomography/computed tomography (PET/CT) in breast cancer
    Mohamed Shawky
    Zeinab Abd Elaziz Ali
    Dina Hamdy Hashem
    Mohamed Houseni
    [J]. Egyptian Journal of Radiology and Nuclear Medicine, 51
  • [9] Role of positron-emission tomography/computed tomography (PET/CT) in breast cancer
    Shawky, Mohamed
    Ali, Zeinab Abd Elaziz
    Hashem, Dina Hamdy
    Houseni, Mohamed
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2020, 51 (01):
  • [10] FDG (18 fluorodeoxyglucose) : Positron emission tomography and breast cancer
    Menkès, MCJ
    Milhaud, MG
    Paolaggi, MJB
    de Gennes, MJL
    Picard, MJD
    Boulu, MR
    Nordmann, MR
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2005, 189 (05): : 975 - 978
12345